The fine line between harm reduction and harm production - Development of a clinical policy on femoral (groin) injecting

European Addiction Research

Volumn 14, Issue 4, 2008, Pages 213-218

  Zador, Deborah ^a,d   Lintzeris, Nick ^a,c   Van Der Waal, Rob ^b   Miller, Peter ^a   Metrebian, Nicola ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d Justice Health   (Australia)

Author keywords

Deep venous thrombosis; Groin injecting; Heroin dependence; Injecting drug users

Indexed keywords

DIAMORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG USE; FEMALE; FEMORAL VEIN; HEALTH CARE POLICY; HEROIN DEPENDENCE; HUMAN; INGUINAL REGION; INJECTION SITE ABSCESS; INJECTION SITE INFLAMMATION; INJECTION SITE RASH; INJECTION SITE REACTION; INJECTION SITE THROMBOSIS; MALE; PATIENT CARE; PRIORITY JOURNAL;

ADULT; FEMALE; FEMORAL VEIN; FEMUR; GROIN; HARM REDUCTION; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 53549132533     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141646     Document Type: Article

References (14)

1. Darke S, Ross J, Kaye S: Physical injecting sites among injecting drug users in Sydney Australia. Drug Alcohol Depend 2001;62:77-82.
2. Rhodes T, Stoneman A, Hope V, Hunt N, Martin A, Judd A: Groin injecting in the context of crack cocaine and homelessness; from 'risk boundary' to 'acceptable risk'? Int J Drug Policy 2006;17:164-170.
3. Maliphant J, Scott J: Use of the femoral vein, ('groin injecting') by a sample of needle exchange clients in Bristol, UK. Harm Reduct J 2005;2:1-6.
4. Rhodes T, Briggs D, Kimber J, Holloway G: Crack-heroin speedball injection and its implications for vein care: qualitative study. Addiction 2007;102:1782-1790.
5. Syed FF, Beeching NJ: Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. QJM 2005;98:139-145.
6. McColl MD, Tait RC, Greer IA, Walker ID: Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol 2001;112:641-643.
7. Linnell M: Going in the Groin: Injecting in the Femoral Vein. Manchester, Lifeline Publications, 2003.
8. Lintzeris N, Strang J, Metrebian N, Byford S, Lee S, Hallam C, Zador D: Methodology for randomized Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimized oral methadone treatment in the UK. Harm Reduct J 2006;3:28.
9. Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, et al: Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health 2007;84:552-562.
10. Solai S, Dubois-Arber F, Benninghoff F, Benaroyo L: Ethical reflections emerging during the activity of a low threshold facility supervised drug consumption room in Geneva, Switzerland. Int J Drug Policy 2006;17:17-22.
11. White W L, Popovits RM: Critical Incidents: Ethical Issues in the Prevention and Treatment of Addiction, ed 2. Bloomington, Chestnut Health Series, 2001.
12. Miller PG, Lintzeris N, Forzisi L: Femoral injecting as an ethical boundary for harm reduction practice. Int J Drug Policy, in press.
13. Rhodes T, Kimber J: Safer groin injecting interventions are needed and justifiable as part of a harm reduction approach. Addiction 2007;102:1987-1988.
14. MSIC Evaluation Committee. Final report of the evaluation of the Sydney Medically Supervised Injecting Centre. Sydney, MSIC, 2003.